Non-inferior efficacy of ultrasound-guided posterior spinal nerve branch 5% glucose injection in patients with posterior lumbar spinal nerve entrapment syndrome

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200067169

Enrollment

Unknown

Registered

2022-12-28

Start date

2023-01-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar spinal nerve posterior branch entrapment syndrome

Interventions

Test group (5% dextrose injection):5% dextrose injection

Control group (anti-inflammatory and analgesic compound solution):Anti-inflammatory and analgesic compound injection

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for posterior lumbar spinal nerve entrapment syndrome 2. Age = 18 years 3. NRS score = 4 points 4. After the diagnostic posterior lumbar spinal nerve block, the pain and discomfort are relieved by more than 50%.

Exclusion criteria

Exclusion criteria: 1. Spinal origin specific low back pain (moderate to severe disc herniation, spinal stenosis, spondylolisthesis and other diseases; tumors, tuberculosis, infection, fractures, immune diseases such as rheumatoid, ankylosing spondylitis) 2. low back pain due to pelvic visceral disease 3. Random blood glucose >11.1mmoL/L 4. Refusal to participate in this test

Design outcomes

Primary

Measure	Time frame
NRS score;	—

Secondary

Measure	Time frame
ODI Low Back Pain Score;Fasting end blood glucose;Efficiency;Recurrence rate;	—

Countries

China

Contacts

Public ContactShen Wen

Xuzhou Medical University Hospital

shenwen670201@163.com13815311266

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026